Leon Chen is a Partner at The Column Group, where he invests in biotechnology and life sciences companies across the United States, with a focus on the San Francisco Bay Area and the U.S. West Coast. He backs companies from seed through late-stage venture and private equity, and has participated in post-IPO investments. The Column Group raised over $400 million in February 2024. His investments include Eikon Therapeutics, Hexagon Bio, Kallyope, Cajal Neuroscience, and A2 Biotherapeutics. Before The Column Group, he was a Venture Partner at OrbiMed, a Partner at Skyline Ventures, an Entrepreneur in Residence at Venrock Associates, and the founder of KAI Pharmaceuticals; earlier in his career he was a PhD student at Stanford. He studied at Stanford University Graduate School of Business and lives in Palo Alto, California.
Leon Chen, Partner @ The Column. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Leon Chen from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Leon
Map your path to Leon instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Leon
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.